These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26498740)

  • 1. Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population.
    Wittenberg E; Bray JW; Aden B; Gebremariam A; Nosyk B; Schackman BR
    Addiction; 2016 Apr; 111(4):675-84. PubMed ID: 26498740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint Utility Estimators in Substance Use Disorders.
    Wittenberg E; Bray JW; Gebremariam A; Aden B; Nosyk B; Schackman BR
    Value Health; 2017 Mar; 20(3):458-465. PubMed ID: 28292491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Opioid Misuse Among Individuals Aged 12 to 21 Years in the US.
    Warren LK; Adams J; Bobashev G
    JAMA Netw Open; 2023 Jun; 6(6):e2316276. PubMed ID: 37261827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life among prescription opioid-dependent patients: Results from a multi-site study.
    Griffin ML; Bennett HE; Fitzmaurice GM; Hill KP; Provost SE; Weiss RD
    Am J Addict; 2015 Jun; 24(4):308-14. PubMed ID: 25808055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility scores for vesicoureteral reflux and anti-reflux surgery.
    Nelson CP; Routh JC; Logvinenko T; Rosoklija I; Kokorowski PJ; Prosser LA; Schuster MA
    J Pediatr Urol; 2015 Aug; 11(4):177-82. PubMed ID: 25975732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence.
    Chetty M; Kenworthy JJ; Langham S; Walker A; Dunlop WC
    Addict Sci Clin Pract; 2017 Feb; 12(1):6. PubMed ID: 28235415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Views of Rural US Adults About Health and Economic Concerns.
    Findling MG; Blendon RJ; Benson JM; Sayde JM; Miller CE
    JAMA Netw Open; 2020 Jan; 3(1):e1918745. PubMed ID: 31913496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid maintenance therapy in Switzerland: an overview of the Swiss IMPROVE study.
    Besson J; Beck T; Wiesbeck G; Hämmig R; Kuntz A; Abid S; Stohler R
    Swiss Med Wkly; 2014; 144():w13933. PubMed ID: 24706398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-utility analysis of methadone maintenance treatment in Lithuania.
    Vanagas G; Padaiga Z; Bagdonas E
    Medicina (Kaunas); 2010; 46(4):286-92. PubMed ID: 20571298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic Evaluation of Interventions to Address Opioid Misuse: A Systematic Review of Methods Used in Simulation Modeling Studies.
    Barbosa C; Dowd WN; Zarkin G
    Value Health; 2020 Aug; 23(8):1096-1108. PubMed ID: 32828223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder.
    Velez FF; Luderer HF; Gerwien R; Parcher B; Mezzio D; Malone DC
    Postgrad Med; 2021 May; 133(4):421-427. PubMed ID: 33593201
    [No Abstract]   [Full Text] [Related]  

  • 14. Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population.
    McDermott KA; Griffin ML; Connery HS; Hilario EY; Fiellin DA; Fitzmaurice GM; Weiss RD
    J Clin Psychiatry; 2015 Feb; 76(2):189-94. PubMed ID: 25562462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social Stigma Toward Persons With Prescription Opioid Use Disorder: Associations With Public Support for Punitive and Public Health-Oriented Policies.
    Kennedy-Hendricks A; Barry CL; Gollust SE; Ensminger ME; Chisolm MS; McGinty EE
    Psychiatr Serv; 2017 May; 68(5):462-469. PubMed ID: 28045350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring family HRQoL spillover effects using direct health utility assessment.
    Prosser LA; Lamarand K; Gebremariam A; Wittenberg E
    Med Decis Making; 2015 Jan; 35(1):81-93. PubMed ID: 25057048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of costs and utilization among buprenorphine and methadone patients.
    Barnett PG
    Addiction; 2009 Jun; 104(6):982-92. PubMed ID: 19466922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer and quality of life in spousal dyads: spillover in couples with and without cancer-related health problems.
    Litzelman K; Green PA; Yabroff KR
    Support Care Cancer; 2016 Feb; 24(2):763-771. PubMed ID: 26143040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Concomitant Misuse of Fentanyl in Subjects on Opioid Maintenance Treatment.
    Krause D; Plörer D; Koller G; Martin G; Winter C; Adam R; Canolli M; Al-Iassin J; Musselmann R; Walcher S; Schäfer F; Pogarell O
    Subst Use Misuse; 2017 Apr; 52(5):639-645. PubMed ID: 28157415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.